|
NEWS, EVENTS, and DEADLINES
August 20, 2025
| | Introducing the New NJ ACTS T32 Fellows | | NJ ACTS congratulates the latest cohort of fellows chosen for the T32 program. The T32 Fellows Program prepares future generations of translational researchers by providing rigorous training in translational research methodology, translational science principles, and interdisciplinary skills, together with a multidisciplinary mentoring program. | | |
Alison Miller
Augmenting Mature Gene Expression in Stem Cell-Derived Motor Neurons
| |  | |
Antonia Kaz
Oak Galls as a Source of Surface-Acting Antibacterial Compounds
| | | |
Callan O’Shea
Cerebello-Striatal Signaling in Learning and Decision-Making: Circuit Dynamics in a Mouse Model of Autism
| | | |
Emily Hyde
Targeting Tryptophan Degradation to Promote Radiosensitivity in Triple Negative Breast Cancer
| | | |
Hima Tallam
AI Optimized Antibody Cocktails for Targeted Alpha Radiopharmaceutical Therapy against Metastatic Liver Cancers
| | | |
Isabel Brandtjen
Mechanosensor for Gene Therapy
| | | |
Nedine Abdelhamid
Impact of Delayed Recovery of Pre-Transplant Immune Dysfunction on Post-Transplant Outcomes
| | | |
To learn more about the NJ ACTS T32 Program, please visit our website.
| | | Request for Applications - NJ ACTS Element E | | |
NJ ACTS Element E
Funding Opportunity
This RFA solicits innovative projects that address significant roadblocks in clinical and translational science (CTS). Faculty investigators at Rutgers University, Princeton University, New Jersey Institute of Technology, and the RWJBarnabas Health System are eligible to apply.
Projects should:
- Focus on strategies and/or innovations to overcome truly significant challenges in clinical and translational research
- Improve dissemination and/or implementation of evidence-based interventions
- Address a translational research question in a particular disease or intervention context, but provide insights or innovations that are generalizable across different diseases and/or translational research projects
- Increase efficiency and/or effectiveness of research translation
-
Budget up to $162,500 in direct costs per year for up to two years.
| | | | | | |
Key Dates:
RFA Release: August 4, 2025
Letter of Intent Deadline: September 15, 2025 (LOI Form Link)
Notification of Projects Selected for Full Proposals: Early October 2025
Full Proposal Deadline: November 21, 2025 by 5:00 PM EST
Award Notification: January 2026
Earliest State Date: May 1, 2026
| | Upcoming NJ ACTS, Rutgers, Princeton and NJIT Events | | |
Ascendus is the Northeast I-Corps Hub’s advanced training program for graduates of Propelus, which explores the customer perspective to inform how a discovery or innovation can become the basis of a successful startup or venture, that have innovations ready for national-level commercialization.
Program Features:
- Based on NSF I-Corps Teams curriculum (6-week program)
- Open to undergrads and non-university innovations
- $2,000 team stipend
- Cohort begins: Oct 6, 2025
| | |
Clinician Research Experiential Summer Training (CREST) Program
For the first time this year, the newly launched Clinician Research Experiential Summer Training (CREST) Program launched with five MD students from the RWJMS Summer Research Program and five from the PharmD program. The inaugural first year MD cohort includes Jeeshan Ahmed, Jake Gluckman, Julia Sales, Sophie Silverstein, and Catherine Vandermillen. The first year pharmacy student cohort includes Collin Drazek, Kelly Huang, Taylor Troncoso, Yuchi Zhang, and Fathima Syed.
The CREST initiative is co-directed by Céline Gélinas, PhD (RWJMS) and Lauren Aleksunes, PharmD, PhD, DATB (Ernest Mario School of Pharmacy, EMSOP).
Designed as an immersive, inter-professional training experience, CREST focuses on translational science and brings first-year medical students from RWJMS and first-year pharmacy students from EMSOP under the New Jersey Alliance for Clinical and Translational Science (NJ ACTS).
| | |
Real-world Mastery of Essential Skills
in a Clinical Research Coordinator Graduate Program
The 2020 pandemic revealed a significant unmet need in training and recruitment of clinical research coordinators (CRC) and managers. In response to this need, Rutgers Health, Clinical Research Management (CRM) program, with support from NJ ACTS, developed an initiative to provide scholarships to establish a “Clinical Research Experience” (CRE).
The CRE focuses on building an entry-level Clinical Research Coordinator (CRC) workforce. The six-month precepted CRE is embedded in an accelerated master’s degree and demonstrates a skill-based approach to developing CRC resources. The experiential education is designed for academic medical centers (AMCs) to foster the development of qualified research coordinators. The CRE model supports “teach one, see one, do one” coupled with preceptor-evaluated feedback to cultivate clinical research competency.
Read the Full Article
| | Rutgers Technology Transfer Traineeship | | |
The Office for Research offers a Technology Transfer Traineeship program for postdocs, graduate students and Master of Business and Science students who are interested in pursuing careers in Intellectual Property Law, Business Development, and/or Academic Technology Transfer. We are currently accepting applications, and we are hoping to get this message to as many potential applicants as possible. If you all wouldn't mind forwarding this along to your applicable distribution lists, we would really appreciate it.
Interested applicants should fill out the form below and email it along with their CV and a brief statement on the nature of their interest to shemaila.sultana@rutgers.edu by 08/21/2025.
| | CTSA Requests For Information (RFI) | | |
NJ ACTS Engagement with State and Local Government
Respond to RFI by August 29th
NCATS is interested in understanding how CTSAs are engaging with state and local governments in seven domains:
| |
- Leadership and Advisory Roles
- Advocacy & Policy Development
- NOFO for State-Funded Research
| |
- Workforce Development
- Training & Education
- Entrepreneurism & Innovation
- Contract Services
| | |
BERD was created to enhance clinical and translational research across the NJ ACTS community by providing professional, high-quality study design, quantitative and qualitative (mixed methods) data analysis, survey research and data management services, development of innovative methodologies, as well as extensive group and individual training and instruction in biostatistics, epidemiology, and research design. For studies involving genetics, BERD works with the GREAT core to help design studies and develop the statistical analysis.
Rutgers University Biostatistics & Epidemiology Services (RUBIES) is a center within Rutgers Health and the Rutgers School of Public Health that provides fee-for statistical support, including design, programming, data management, and data analysis, to investigators throughout Rutgers University. RUBIES team members complete requested services with the Faculty Director or other associated Faculty members where appropriate.
| | Community Scientist Badge | | |
Do You Want Additional Professional Credentials?
Take Advantage of the NJ ACTS Badge Program
NJ ACTS enthusiastically supports the development of new skills and expertise by developing and offering the research workforce a variety of digital badges. Badges can demonstrate mastery of materials and competence in a set of skills and can help prepare the earner for new career opportunities.
All NJ ACTS Badges are available at: https://njacts.rbhs.rutgers.edu/education-training/badges/
| | |
Community Scientist Program
The Community Scientist Program is a training and education program designed to engage the community in research by fostering partnerships between community members and investigators. It is designed to provide community-friendly training in ethics and responsible conduct of research to community members, as well as provide opportunities for networking with researchers and other community scientists. The program is comprised of two components: (1) CIRTification: Community Involvement in Research Training and (2) expert-led Community Conversations.
Community Conversations will be 1.5 hours and conducted via Zoom.
| | |
NIA Small Business Programs: SBIR/STTR Funding Standard Deadline
The NIH Small Business Programs at NIA are seeking innovations for healthy aging. Researchers or entrepreneurs innovating for healthy aging are encouraged to apply.
Apply by September 5 at 5:00 pm
National Science Foundation Translation to Practice (NSF TTP)
The NSF Translation to Practice (NSF TTP) program aims to invest in use-inspired and translational research, with a particular focus on fostering cross-sector partnerships that will catalyze the effective and efficient translation of research into practice, all the while advancing entrepreneurial education for all Americans.
Apply by September 16 at 5:00 pm
| | NCATS, NIH, and Federal News and Events | |
NCATS Rare Diseases Are Not Rare!
2025 Challenge Prize Competition
The goals of this challenge are to:
(1) Raise awareness for all rare diseases and the people they affect in a collective manner
(2) Highlight the need for cross-cutting research and development of new treatments using multi-disease models
(3) Increase meaningful engagement with the rare disease community
NCATS is seeking innovative ways to communicate with others and educate the public about rare diseases through art disseminated on various platforms by means of changing the way we think about the problem, the way we fund and do research – Ultimately making rare disease drug development more efficient, bringing attention to rare diseases so that they can gain more medical research interest and support, thereby improving lives. Read More
The anticipated Challenge Launch Date is September 2025.
| |
Collaboration Webinars from the
Hear from CTSA TIN experts on trial-related topics to improve your project
| | |
Informed Consent Guidance Manuals and Best Practices & Strategies for Recruiting
September 17
12 - 1 pm
Register
| | | |
Using Behavior, Economics and Technology to Improve Population Health Outcomes
October 15
12 - 1 pm
Register
| | | |
Decentralized Trial Design
December 1
12 - 1 pm
Register
| | | |
Apply for the Translational Science Interagency Fellowship Program -NCATS jointly sponsors the Translational Science Interagency Fellowship (TSIF) with the U.S. Food and Drug Administration to train fellows in translational science and regulatory science. Learn More about the Program
| |
NJ ACTS is a partnership between Rutgers, NJIT, Princeton, and RWJ Barnabas Health. NJ ACTS advances clinical and translational science to develop new therapies and treatments and improve population health.
| | |
This newsletter is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UM1TR004789 to Rutgers University. The content is solely the responsibility of the authors and does not represent the official views of the NIH.
New Jersey Alliance for Clinical and Translational Science
89 French St., Suite 4211
New Brunswick, NJ
Copyright 2020 New Jersey Alliance for Clinical and Translational Science, all rights reserved
Send story ideas to NJACTS@rbhs.rutgers.edu
UL1TR003017 (pre-5/1/2024), UM1TR004789 (starting 5/1/2024), KL2TR003018 and TL1TR003019 (pre-5/1/2024), K12TR004788(starting 7/1/2024), T32TR004782 (starting 9/1/2024), R25TR004777 (starting 9/1/2024)
| | | | |
